Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2018-07
  • Nigericin Sodium Salt: Technical Guidance for Ion Transport

    2026-07-02

    Nigericin Sodium Salt: Technical Guidance for Ion Transport Assays

    What This Product Solves

    Nigericin sodium salt is designed for scientific workflows that require controlled manipulation of ion gradients across biological membranes. As a potassium ionophore, it enables researchers to exchange K+ for H+ ions across lipid bilayers, facilitating experiments focused on cytoplasmic pH regulation, ion transport, and platelet aggregation modulation. Its selectivity for transporting lead (Pb2+) ions, even in the presence of physiological calcium and magnesium, further supports its use in toxicology or metal ion transport studies. However, its insolubility in water and DMSO restricts its application to protocols compatible with ethanol as a vehicle. The compound is intended strictly for research use and is not suitable for diagnostic or medical purposes.

    For an in-depth exploration of Nigericin sodium salt's mechanistic basis and optimal research applications, see this review on potassium ionophore activity. Protocol design and troubleshooting strategies are further discussed in this practical guidance article.

    Protocol Parameters

    • Assay: Ion transport/cytoplasmic pH modulation
      Value with unit: 2 μM final concentration
      Applicability: Typical for in vitro workflows on cell monolayers or isolated organelles
      Rationale: Supports rapid and controlled changes in pH and membrane potential within short timeframes.
      Source type: product information
    • Assay: Platelet aggregation modulation
      Value with unit: Incubation time of 2 minutes
      Applicability: Short-term exposure recommended for functional studies of platelet aggregation
      Rationale: Prolonged exposure may cause non-physiological effects due to sustained ion gradient disruption.
      Source type: product information
    • Assay: Stock solution preparation
      Value with unit: Soluble in ethanol at ≥74.7 mg/mL; insoluble in water/DMSO
      Applicability: For all workflows requiring a concentrated stock solution
      Rationale: Using ethanol ensures adequate solubility and prevents precipitation during dilution; gentle heating or sonication may assist dissolution.
      Source type: product information
    • Assay: Storage conditions
      Value with unit: Store solid at -20°C; avoid long-term storage of prepared solutions
      Applicability: Critical for maintaining compound purity and activity
      Rationale: Minimizes compound degradation and ensures batch-to-batch reproducibility.
      Source type: product information

    Workflow Setup and QC Checklist

    • Vehicle Preparation: Prepare Nigericin sodium salt stock solutions in 100% ethanol. Confirm complete dissolution, using gentle heating at 37°C or ultrasonication as needed. Avoid water or DMSO as solvents to prevent precipitation and loss of activity.
    • Aliquoting and Storage: Store solid material at -20°C in tightly sealed containers. Prepare working stocks immediately before use. Avoid repeated freeze-thaw cycles and do not store diluted solutions long-term.
    • Working Concentration Validation: Perform titration assays to confirm the optimal concentration for your specific cell type and endpoint. Begin with 2 μM and adjust as required based on experimental readouts (e.g., pH change, platelet aggregation).
    • Incubation Time Control: Limit incubation to short periods (typically ~2 minutes for platelet studies) to reduce off-target effects and cytotoxicity from prolonged exposure.
    • Quality Control: Confirm compound integrity via analytical methods (e.g., HPLC) if available, particularly after shipment or prolonged storage. Discard stock solutions showing precipitation or discoloration.
    • Documentation: Record batch numbers, preparation dates, and storage conditions for all reagent preparations. Document all deviations from standard protocol for reproducibility and troubleshooting.

    Common Failure Modes and Fixes

    • Incomplete Dissolution in Vehicle: If precipitation is observed, reheat the ethanol solution gently or apply ultrasonication. Do not attempt to dissolve in water or DMSO, as the product is insoluble in these solvents.
    • Loss of Activity Due to Degradation: Use freshly prepared working solutions. Avoid storing diluted stocks for more than a few hours at room temperature or 4°C. Always store the solid at -20°C, protected from moisture.
    • Variable Biological Response: Confirm that ethanol concentration in final assay is kept minimal (typically ≤1%) to prevent solvent effects on cells. Include vehicle-only controls in all experiments.
    • Non-specific Cellular Toxicity: If cytotoxicity is observed beyond expected ionophore effects, reduce Nigericin concentration or shorten incubation time. Verify that the product is not expired or contaminated.
    • Batch-to-Batch Variability: Use the same lot for comparative studies whenever possible and refer to the supplied certificate of analysis for purity (98%). Document all batch details in lab records.

    Scope and Limitations

    Nigericin sodium salt is optimized for in vitro and cell-based assays where precise control of K+/H+ exchange, cytoplasmic pH regulation, or platelet aggregation modulation are required. Its selective transport of Pb2+ ions supports specialized toxicology workflows. However, the compound's insolubility in water and DMSO means it cannot be used in strictly aqueous systems or protocols requiring DMSO as a vehicle. Long-term stability of working solutions is poor; freshly prepared stocks are essential for reproducibility. Nigericin sodium salt is not appropriate for diagnostic, therapeutic, or clinical use and should not be used in protocols with extended exposure times or in vivo studies unless additional compatibility data is generated.

    Conclusion

    Nigericin sodium salt is a technical tool for researchers requiring robust and selective modulation of ion transport across biological membranes. Its implementation demands strict attention to solvent compatibility, concentration control, and storage discipline. For detailed product specifications and ordering, refer to Nigericin sodium salt at APExBIO. Leverage established protocols and troubleshooting recommendations for reproducible results in cytoplasmic pH regulation, platelet aggregation, and metal ion transport workflows.